Scott,--Toxic Financing At least one piece of g
Post# of 9122
At least one piece of good news from that chat is that Brett has resisted toxic financing deals, which most Pink Sheet companies thrive on; and then, after the deal is signed, shareholders get screwed through dilution and usually reverse splits.
So, kudos to Brett for that. Let's hope he can pull off a patent sale for enough money to expand production of the N-Assay test. Still can't understand why that test is not generating interest from large med-tech companies. Anyone have any thoughts on that.